Study findings could lead to novel ways to overcome tumor resistance to immunotherapies
Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different "program" that makes them less effective than immune cells in patients whose cancers respond to these immune treatments, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy.
Johns Hopkins Kellien Smith Emily Henderson Johns Hopkins Bloomberg Kimmel Institute Of Immunotherapy Johns Hopkins Kimmel Cancer Center Kimmel Institute
Source: news-medical.net